youtube_live
Q3 2026 earnings • released • EPS beat +11.55% • Revenue beat +3.01%
See resultschevron_right
AMGN:NASDAQ
Amgen Inc
US$478.48
arrow_upward
+3.73%(+17.22) 1D
US$477.40
arrow_downward
-0.23% (-1.08)bedtimeAfter hours
Closed: ኖቬም 4, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN...
Open
US$479.61
High
US$482.48
Low
US$464.13
Mkt. cap
258.68 ቢ
Avg. vol.
2.71 ሚ
Volume
4.62 ሚ
Dividend
2.11%
Quarterly dividend
US$2.52
Ex-dividend date
21 ኦገስ 2026
P/E ratio
47.05
52-wk high
US$482.48
52-wk low
US$302.13
EPS
US$10.17
Beta
0.43
Shares outstanding
540.63 ሚ
No. of employees
32 ሺ
Open
US$479.61
High
US$482.48
Low
US$464.13
Mkt. cap
258.68 ቢ
Avg. vol.
2.71 ሚ
Volume
4.62 ሚ
Dividend
2.11%
Quarterly dividend
US$2.52
Ex-dividend date
21 ኦገስ 2026
P/E ratio
47.05
52-wk high
US$482.48
52-wk low
US$302.13
EPS
US$10.17
Beta
0.43
Shares outstanding
540.63 ሚ
No. of employees
32 ሺ
News stories
From web sources and news partners
GuruFocus
·
ከ3 ሰዓቶች በፊት
AMGN Maintained by UBS -- Price Target Raised to $530
News Corp
·
ከ7 ሰዓቶች በፊት
Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains
MarketWatch
·
ከ7 ሰዓቶች በፊት
Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Quantisnow
·
ከ7 ሰዓቶች በፊት
Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees31.5 ሺ
Founded1980
Headquartersታውዘንድ ኦካስ, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorBiotechnology
Industry-
Websiteamgen.com